Bayesian Capital Management, LP
- SEC CIK
- 0001632551
- Latest filing
- Aug 14, 2026
ADMA holding history
Adma Biologics, Inc. in every 13F filed by Bayesian Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −47,700−100.0% | Sold out | Holders |
| Q1 2026 | 47,700 | $429.8K | 0.5% | +47,700 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −15,615−100.0% | Sold out | Holders |
| Q2 2024 | 15,615 | $174.6K | <0.1% | +15,615 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −57,915−100.0% | Sold out | Holders |
| Q4 2023 | 57,915 | $261.8K | <0.1% | −18,185−23.9% | Reduced | Holders |
| Q3 2023 | 76,100 | $272.4K | <0.1% | +76,100 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −11,146−100.0% | Sold out | Holders |
| Q1 2023 | 11,146 | $36.9K | <0.1% | −30,854−73.5% | Reduced | Holders |
| Q4 2022 | 42,000 | $163.0K | <0.1% | +42,000 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −55,300−100.0% | Sold out | Holders |
| Q2 2022 | 55,300 | $109.0K | <0.1% | +55,300 | New | Holders |